BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

LINKPHARMACHEM01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

LINKPHARMACHEM01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
31-Jan-2024	BC	LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve inter-alia the unaudited financial resul	09-Feb-2024
31-Oct-2023	BC	LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve This is to inform that pursuant to the pr	08-Nov-2023
08-Nov-2023	BC	Pursuant to Regulations 30 and 33 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Comp	08-Nov-2023
31-Oct-2023	BC	Resignation of Chief Financial Officer(CFO) of the Company with effect from 31.10.2023 after working hours due to almost attaining the age of retirement.	31-Oct-2023
29-May-2023	BC	1. Approved the Re-appointment of Mr. Satish G. Thakur (DIN: 00292129) as Chairman and Whole-time Director of the Company for a period of 3 years with effect from 24th June, 2023 for a period of 3 ye	24-Sep-2023

No Rights has been declared by LINKPHARMACHEM

Book Closure

Record Date	Split Date	Purpose
09-Feb-2024	-	LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve inter-alia the unaudited financial resul
08-Nov-2023	-	LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve This is to inform that pursuant to the pr
08-Nov-2023	-	Pursuant to Regulations 30 and 33 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Comp
31-Oct-2023	-	Resignation of Chief Financial Officer(CFO) of the Company with effect from 31.10.2023 after working hours due to almost attaining the age of retirement.
24-Sep-2023	-	1. Approved the Re-appointment of Mr. Satish G. Thakur (DIN: 00292129) as Chairman and Whole-time Director of the Company for a period of 3 years with effect from 24th June, 2023 for a period of 3 ye

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Jubilant Industries Ltd ₹1,143.25(-27.20/-2.32%)	1,143.25	-27.20	1,722.55	172.01	0.00	5.57
Linde India Ltd ₹8,281.00(-174.00/-2.06%)	8,281.00	-174.00	70,620.37	105.60	167.87	21.96
Gujarat Alkalies & Chemicals Ltd ₹793.35(+4.10/0.52%)	793.35	+4.10	5,826.36	15.56	0.00	0.93
Bodal Chemicals Ltd ₹77.10(-0.65/-0.84%)	77.10	-0.65	969.84	8.90	197.72	0.86
Omkar Speciality Chemicals Ltd ₹7.10(-0.15/-2.07%)	7.10	-0.15	14.61	-8.39	0.00	-0.09

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	7.94	6.05	7.88	9.29	9.36	8.47
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	7.94	6.05	7.88	9.29	9.36	8.47
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.37	-0.03	0.31	-0.03	0.08	0.61
Total Income	8.31	6.02	8.18	9.27	9.45	9.08
Total Expenditure	7.66	6.94	8.84	9.01	8.72	7.53
PBIDT	0.65	-0.91	-0.66	0.26	0.73	1.54
Interest	0.23	0.22	0.23	0.26	0.19	0.14
PBDT	0.42	-1.13	-0.88	0.00	0.54	1.40
Depreciation	0.27	0.26	0.26	0.23	0.24	0.23
Tax	0.00	0.01	0.00	0.01	0.06	0.19
Deferred Tax	-0.07	-0.38	-0.32	-0.05	0.06	0.03
Reported Profit After Tax	0.22	-1.02	-0.82	-0.19	0.18	0.96
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.22	-1.02	-0.82	-0.19	0.18	0.96

EPS (Unit Curr.)	0.50	-2.30	-1.85	-0.44	0.40	2.16
EPS (Adj) (Unit Curr.)	0.50	-2.30	-1.85	-0.44	0.40	2.16
Calculated EPS (Unit Curr.)	0.50	-2.30	-1.85	-0.44	0.40	2.16
Calculated EPS (Adj) (Unit Curr.)	0.50	-2.30	-1.85	-0.44	0.40	2.16
Calculated EPS (Ann.) (Unit Curr.)	1.99	-9.20	-7.41	-1.74	1.62	8.66
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.99	-9.20	-7.41	-1.74	1.62	8.66
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.44	4.44	4.44	4.44	4.44	4.44
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	8.19	-15.04	-8.38	2.80	7.80	18.18
PBDTM(%)	5.29	-18.68	-11.17	0.00	5.77	16.53
PATM(%)	2.77	-16.86	-10.41	-2.05	1.92	11.33

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.44	4.44	4.44	4.44	4.44	4.44
Reserves Total	10.60	10.03	8.12	6.99	5.94	5.35
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	15.04	14.47	12.56	11.43	10.38	9.79
Secured Loans	1.98	2.90	3.16	3.17	1.71	1.98
Unsecured Loans	6.78	3.49	0.50	0.39	0.93	0.73
Total Debt	8.76	6.39	3.66	3.56	2.64	2.71
Total Liabilities	23.80	20.86	16.22	14.99	13.02	12.50
APPLICATION OF FUNDS :
Gross Block	13.88	12.74	11.74	11.56	11.58	11.43
Less : Accumulated Depreciation	4.88	3.95	3.03	2.76	2.45	1.67
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	9.00	8.79	8.71	8.80	9.13	9.76
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.21	0.00	0.00	0.43	0.01
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.64	4.52	0.03	0.03	0.03	0.03
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	12.25	4.76	2.50	1.63	2.87	2.63
Sundry Debtors	3.63	5.37	5.55	4.99	3.04	3.18
Cash and Bank	0.20	0.88	4.86	2.05	0.20	0.18
Loans and Advances	1.47	2.57	2.24	0.41	1.08	0.58
Total Current Assets	17.55	13.57	15.14	9.09	7.19	6.58
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	7.41	6.97	8.63	3.06	3.95	3.90
Provisions	0.33	0.15	0.15	0.00	0.00	0.00
Total Current Liabilities	7.74	7.12	8.78	3.06	3.95	3.90
Net Current Assets	9.81	6.44	6.36	6.02	3.24	2.68
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.24	0.02	0.02	0.01	0.01	0.33
Deferred Tax Liability	0.96	0.96	0.88	0.93	1.01	1.08
Net Deferred Tax	-0.72	-0.94	-0.86	-0.92	-1.00	-0.75
Total Assets	21.73	19.02	14.24	13.94	11.84	11.73
Contingent Liabilities	0.23	0.22	0.00	0.00	1.79	1.79

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.27	4.22	1.87	0.02	0.08
Net Cash from Operating Activities	-1.71	-1.26	4.84	2.95	1.36
Net Cash Used In Investing Activities	-0.08	-4.97	-2.16	-1.66	-0.96
Net Cash Used In Financing Activities	1.61	2.27	-0.33	0.55	-0.46
Net Inc./Dec In Cash And Cash Equivalents	-0.17	-3.95	2.35	1.85	-0.05
Cash And Cash Equivalents At End Of The Year	0.09	0.27	4.22	1.87	0.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

51.49%

FII Shareholding

0.00%

DII Shareholding

0.02%

Public Shareholding

48.49%

**Promoter pledged shareholding 51.49%

About Link Pharma Chem Ltd

Link Pharma Chem Ltd is in the Chemicals sector, having a market capitalization of Rs. 19.53 crores. It has reported a sales of Rs. 7.94 crores and a net profit of Rs. 0.22 crores for the quarter ended December 2018. The company management includes S G Thakur, S G Thakur,Rishikesh S.Thakur,S B Dhatrak,Devang U Shah,Rachna Ghai (Link Pharma Chem Ltd) among others.

Chairman

S G Thakur

Registered office

162,GIDC Ind Estate Nandesari,Vadodara,Gujarat,391340

FAX :91-0265-2841351

Background

Incorporation Year1984

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0